#mdpijcm #OpenAccess 🔓 📢We are pleased to share the 369 new articles in Volume 14, Issue 22 👉 https://t.co/htKJsPBKGV #CoverStory An Updated Review of #TopicalTretinoin in #Dermatology: From Acne and Photoaging to Skin Cancer 📌 https://t.co/MhbzOcvKW8 @MediPharma_MDPI

#mdpijcm #HighlyCitedPaper Citations 12 Reducing the Risk of 𝐏𝐫𝐞-𝐄𝐜𝐥𝐚𝐦𝐩𝐬𝐢𝐚 in Women with #PolycysticOvarySyndrome Using a Combination of #Pregnancy Screening, Lifestyle, and Medical Management Strategies 🎯 https://t.co/TAtS7U9Djg 🏬@UOW @UniCanberra @MediPharma_MDPI

#mdpijcm #HighlyCitedPaper Citations 14🙌 Safe and Informed Use of #Gadolinium-Based Contrast Agent in Body #MagneticResonanceImaging: Where We Were and Where We Are 👉 https://t.co/9C3zoDJk5v @MediPharma_MDPI

#IOCDT2026 Submit your abstract NOW! 🦷 Don’t miss the 1st International Online Conference on Dentistry, from 7–9 October 2026. The abstract submission deadline is 5 June 2026. More details: https://t.co/aC0Z2R6749 #Dentistry #Oralhealth @MDPIOpenAccess @MediPharma_MDPI

#mdpijcm #FeaturePaper sharing✨ #VascularDementia: From Pathophysiology to Therapeutic Frontiers 👉 https://t.co/ngeiBRwz7C @MediPharma_MDPI #cerebralsmallvesseldisease; #neuroinflammation

#mdpijcm #Editor’s Choice Paper🔍 Citations 7👏 Innovations in 𝐄𝐚𝐫𝐥𝐲 𝐋𝐮𝐧𝐠 𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧: Tracing the Evolution and Advancements in Screening 📌 https://t.co/wqwfytsj4w @MediPharma_MDPI

#mdpijcm #HighlyReviewed #Editor’s Choice Paper🔍 🙌Updates and Current Knowledge on the Common Forms of #Gastroenteritis: A Review 👉 https://t.co/9gdhGAl9mD @MediPharma_MDPI

#mdpijcm 📢Enjoy the #HighlyCited Paper Citations 12👏 #BloodPressure Variability in #AcuteStroke: A Narrative Review 🙌 https://t.co/8QduVdt9bu 🏬@uoaofficial @MediPharma_MDPI

#mdpijcm #HighlyCitedPaper Citations 20👏 Current Trends and Beyond Conventional Approaches: Advancements in #BreastCancerSurgery 👉 https://t.co/0jkGcYHnFN ✍️@LMaranoAMiSNS @polom_karol @MediPharma_MDPI #imageguidedsurgery; #cancerimaging

#mdpijcm Check out the #Review #GraphicalAbstract 🙌#Predicting New-Onset Atrial Fibrillation in #HypertrophicCardiomyopathy 📌 https://t.co/m3QH7GMf8N @MediPharma_MDPI #atrialfibrillation, #electrocardiogram, #cardiovascularmagneticresonance

#mdpijcm Check out the #review Views 7517, Citations 7👏 #SGLT2Inhibitors: The First Endothelial-Protector for #DiabeticNephropathy 👉 https://t.co/zRpiHbUZM4 by Davide Viggiano et al. 🏬University of Campania @MediPharma_MDPI

#mdpijcm #FeaturePaper sharing✨ 𝐀𝐧𝐭𝐢-𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐨𝐫𝐲 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 for #AtopicDermatitis: A New Era in Targeted Treatment 👉 https://t.co/gV98pHFA7m by Karol Biliński et al. @umed_wroc @MediPharma_MDPI

#mdpijcm #Editor’s Choice Paper🔍 #Catheter-Based Therapies in #AcutePulmonaryEmbolism—Mortality and Safety Outcomes: A Systematic Review and Meta-Analysis 👉 https://t.co/8hMclUNpXo @MediPharma_MDPI 🏬@NYCHealthSystem

#mdpijcm #HighlyCitedPaper Citations 12✨ Different Diagnostic Criteria for Determining the Prevalence of #Sarcopenia in Older Adults: A Systematic Review 👉 https://t.co/diZFuwVE1H @MediPharma_MDPI

#mdpijcm #Editor’s Choice Paper🔍 #TraumaticBrainInjury: Advances in Diagnostic Techniques and Treatment Modalities 🎯 https://t.co/OgqkAKzSxx @MediPharma_MDPI

#mdpijcm #LatestPaper Sharing #GraphicalAbstract Expectations Versus Reality in #InhalationTechnique—A Case–Control Study of Inhalation Technique in Patients with #Asthma or #COPD 👉 https://t.co/D00mQTvqSu #MedicaUniversityofWarsaw @MediPharma_MDPI

#mdpijcm #Editor’s Choice Paper🔍 Citations 10✨ Emulsification of #SiliconeOils: Altering Factors and Possible Complications—A Narrative Review 👉 https://t.co/m5Ap9F4Anm 🏬Wroclaw Medical University @MediPharma_MDPI

#mdpijcm #Editor’s Choice Paper🔍 Views 7959, Citations 4✨ Understanding Treatment Adherence in #ChroniDiseases: Challenges, Consequences, and Strategies for Improvement 👉 https://t.co/iaIsIqbGdV @MediPharma_MDPI #medicationadherence; #oramedication

#mdpijcm #LatestPaper Sharing #GraphicalAbstract #Radiofrequency vs. #MicrowaveAblation in #OsteoidOsteoma: Comparative Outcomes and Prognostic Factors 👉 https://t.co/ri8TqVmC1M @MediPharma_MDPI

#mdpijcm #FeaturePaper sharing✨ Glucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss 🎯 https://t.co/efryjx8gDu @MediPharma_MDPI #GLPIA; #obesity; #type2DM